Article

Intraoperative aberrometry adds value in toric IOL surgery

Use of intraoperative aberrometry significantly improves refractive and visual outcomes after toric IOL implantation, according to a retrospective study presented by Kathryn Hatch, MD.

 

Waltham, MA-Use of intraoperative aberrometry significantly improves refractive and visual outcomes after toric IOL implantation, according to a retrospective study presented by Kathryn Hatch, MD.

“We conducted this study because to our knowledge, there is no report in the peer-reviewed literature evaluating the use of intraoperative aberrometry with toric IOLs,” said Dr. Hatch, private practice, Waltham, MA, and clinical faculty, Brown Alpert Medical School, Providence, RI.

The analysis compared a traditional method group including 27 eyes and an aberrometry group with 37 eyes.

In the traditional method group, IOL cylinder power and axis of alignment were determined based on standard biometry and use of an appropriate toric IOL calculator.

In the aberrometry group, intraoperative aberrometry (ORA, WaveTec Systems) was performed in the aphakic state to determine cylinder power and axis of toric IOL placement, and then IOL placement was refined by pseudophakic refraction.

Use of aberrometry led to a change in cylinder power in about 1 in 4 eyes, in spherical power in about 1 in 3 eyes, and in IOL positioning in about 1 in 3 eyes.

Postoperative refractive astigmatism measured at a mean of about 2 months after surgery was analyzed as the primary outcome measure, and the mean value was significantly less among the aberrometry eyes compared with the traditional method group, 0.46 ± 0.42 D vs. 0.68 ± 0.34 D.

In addition, the chance of a patient being in a lower range of postoperative residual refractive astigmatism increased significantly when intraoperative aberrometry was used. Considering a cutoff of ≤0.5 D, the proportion of eyes falling within that range was about 2.5-fold higher in eyes managed with intraoperative aberrometry compared with the traditional method group, 78% vs. 33%.

Better refractive outcomes translated into better vision-mean logMAR distance UCVA was 0.11 for the aberrometry group and 0.16 for eyes managed with the traditional method, while 67% of the aberrometry group eyes and 39% of the traditional method eyes achieved distance UCVA of 20/25 or better.

“Our findings show that surgeons don’t always get it right the first time with toric IOL selection and positioning,” Dr. Hatch said. “Use of intraoperative aberrometry to guide intraoperative decisions improves outcomes.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.